Moderate to severe Plaque Psoriasis in Adolescents

  • End date
    Dec 31, 2021
Updated on 4 March 2021


This clinical research study is looking at whether an investigational drug can reduce the appearance of plaque psoriasis in adolescents.


About the investigational drug:
The BE CONNECTED study will look at an investigational drug called bimekizumab, which may help to reduce the development of plaque psoriasis. It is designed to neutralize two particular substances produced when the body’s own immune system is too active. These two substances can trigger skin cells to grow faster than needed. If there are too many of these extra skin cells, they build up on the surface of the skin, forming patches of psoriasis.

Your child will receive an injection of bimekizumab under the skin once every 4 weeks at a study center. The study may last up to around 3 years in total. After 20 weeks, there could be the option for your child to receive the injection at home, given by a healthcare provider. In some cases, it may be possible for you to be shown how to give your child the injection.

Who will be joining the study?
Approximately 40 adolescents who have moderate to severe plaque psoriasis will take part in the study across the USA, Canada and Europe.

What will be involved?
During the study, your child will be asked to:
  • Attend regular scheduled visits to the study center and have visits at home
  • Undergo medical procedures and assessments during these visits
There will be no charge for any study-related treatment or care, and any participant may leave the study at any time, for any reason.

Condition Psoriasis and Psoriatic Disorders
Clinical Study IdentifierTX267712
Last Modified on4 March 2021


Yes No Not Sure

Inclusion Criteria

We are looking for young males and females to take part in the BE CONNECTED Study who
Are aged 12–17 years
Have had plaque psoriasis for at least 3 months
Have no other skin conditions
There are other criteria to meet, which will be discussed with you and your child
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note